Patent · US Active

Zika RNA vaccines

US10449244B2 · kind B2 · utility

72Cited by

30References

27Claims

0Family size

Assignee

ModernaTX, Inc. · US

Inventors

Giuseppe Ciaramella · Sudbury, US
Eric Yi-Chun Huang · Boston, US
Kapil Bahl · Medford, US
Tal Zaks · Newton, US
Sunny Himansu · Winchester, US

Key dates

Filing date	Jun 15, 2018
Grant date	Oct 22, 2019
Priority date	—
Expiry date	Jun 15, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aspects of the disclosure describe compositions that comprise RNA polynucleotides having an open reading frame encoding one or more Zika virus antigens. Methods for preparing and using the compositions are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.